InMode Ltd. (NASDAQ:INMD) gapped up prior to trading on Friday . The stock had previously closed at $51.50, but opened at $49.75. InMode shares last traded at $47.62, with a volume of 60,970 shares traded.

Several research firms recently commented on INMD. Barclays lifted their price objective on InMode from $27.00 to $45.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. Zacks Investment Research downgraded InMode from a “strong-buy” rating to a “hold” rating in a report on Wednesday, January 8th. Finally, Robert W. Baird restated an “outperform” rating and set a $45.00 price target (up from $27.00) on shares of InMode in a research note on Wednesday, November 6th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $38.60.

The company’s 50 day moving average price is $41.60. The company has a debt-to-equity ratio of 0.01, a current ratio of 7.83 and a quick ratio of 7.47.

InMode (NASDAQ:INMD) last released its quarterly earnings results on Tuesday, November 5th. The healthcare company reported $0.42 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.29 by $0.13. The business had revenue of $40.01 million during the quarter, compared to the consensus estimate of $35.74 million. InMode had a return on equity of 50.50% and a net margin of 30.33%. The business’s quarterly revenue was up 57.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.26 EPS. Equities analysts forecast that InMode Ltd. will post 1.55 EPS for the current year.

Institutional investors have recently added to or reduced their stakes in the business. Maple Rock Capital Partners Inc. purchased a new position in shares of InMode during the 3rd quarter valued at about $10,755,000. Penserra Capital Management LLC bought a new position in shares of InMode during the 3rd quarter valued at approximately $8,690,000. Millennium Management LLC bought a new position in shares of InMode during the 3rd quarter valued at approximately $1,535,000. Rice Hall James & Associates LLC bought a new position in shares of InMode during the 3rd quarter valued at approximately $1,244,000. Finally, Dean Capital Investments Management LLC bought a new position in shares of InMode during the 3rd quarter valued at approximately $951,000. Institutional investors and hedge funds own 11.14% of the company’s stock.

About InMode (NASDAQ:INMD)

InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. The company offers minimally-invasive aesthetic medical products for procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments.

See Also: Depreciation

Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.